Agilent Technologies (NYSE:A) Price Target Cut to $135.00 by Analysts at Sanford C. Bernstein

Agilent Technologies (NYSE:A) had its price objective reduced by Sanford C. Bernstein from $140.00 to $135.00 in a report released on Tuesday morning,Benzinga reports. They currently have a market perform rating on the medical research company’s stock.

A has been the subject of a number of other reports. JPMorgan Chase & Co. lowered their price target on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a report on Tuesday. Citigroup increased their target price on shares of Agilent Technologies from $150.00 to $165.00 and gave the company a “buy” rating in a research report on Thursday, August 22nd. Bank of America boosted their price target on shares of Agilent Technologies from $140.00 to $147.00 and gave the company a “neutral” rating in a research report on Thursday, August 22nd. UBS Group raised their price objective on Agilent Technologies from $141.00 to $150.00 and gave the stock a “neutral” rating in a report on Thursday, August 22nd. Finally, Evercore ISI boosted their target price on Agilent Technologies from $135.00 to $145.00 and gave the company an “in-line” rating in a report on Tuesday, October 1st. One research analyst has rated the stock with a sell rating, seven have issued a hold rating and eight have given a buy rating to the company. According to data from MarketBeat.com, Agilent Technologies currently has a consensus rating of “Hold” and a consensus price target of $144.07.

Agilent Technologies Stock Down 0.1 %

Shares of A opened at $134.35 on Tuesday. The company’s 50-day simple moving average is $137.74 and its 200-day simple moving average is $137.43. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.37 and a current ratio of 1.78. Agilent Technologies has a 1 year low of $124.10 and a 1 year high of $155.35. The stock has a market capitalization of $38.60 billion, a PE ratio of 27.87, a P/E/G ratio of 5.89 and a beta of 1.07.

Agilent Technologies Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 22nd. Shareholders of record on Tuesday, December 31st will be paid a $0.248 dividend. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.24. This represents a $0.99 annualized dividend and a yield of 0.74%. The ex-dividend date is Tuesday, December 31st. Agilent Technologies’s payout ratio is presently 19.50%.

Insider Transactions at Agilent Technologies

In related news, SVP Dominique Grau sold 9,990 shares of the business’s stock in a transaction that occurred on Thursday, September 26th. The shares were sold at an average price of $145.00, for a total value of $1,448,550.00. Following the completion of the sale, the senior vice president now directly owns 40,011 shares in the company, valued at approximately $5,801,595. The trade was a 19.98 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Hedge Funds Weigh In On Agilent Technologies

A number of large investors have recently modified their holdings of A. Ancora Advisors LLC increased its position in shares of Agilent Technologies by 4.0% in the first quarter. Ancora Advisors LLC now owns 7,226 shares of the medical research company’s stock worth $1,051,000 after acquiring an additional 275 shares in the last quarter. B. Riley Wealth Advisors Inc. boosted its position in Agilent Technologies by 47.9% during the 1st quarter. B. Riley Wealth Advisors Inc. now owns 5,281 shares of the medical research company’s stock worth $768,000 after purchasing an additional 1,711 shares during the period. California State Teachers Retirement System increased its holdings in Agilent Technologies by 1.2% in the 1st quarter. California State Teachers Retirement System now owns 475,029 shares of the medical research company’s stock valued at $69,121,000 after purchasing an additional 5,543 shares in the last quarter. Tidal Investments LLC raised its position in Agilent Technologies by 58.2% in the first quarter. Tidal Investments LLC now owns 17,447 shares of the medical research company’s stock valued at $2,540,000 after purchasing an additional 6,420 shares during the period. Finally, iA Global Asset Management Inc. lifted its stake in shares of Agilent Technologies by 26.2% during the first quarter. iA Global Asset Management Inc. now owns 21,770 shares of the medical research company’s stock worth $3,168,000 after purchasing an additional 4,523 shares in the last quarter.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.